Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
-77.19%
↓ 447% vs avg
Percentile
P0
Near historical low
Streak
2 qtr
Consecutive declineDecelerating
Average
22.24%
Historical baseline
PeriodValue
Q4 2025-77.19%
Q3 2025-23.21%
Q2 2025210.29%
Q1 2025-50.56%
Q4 2024-50.43%
Q3 202419.60%
Q2 20247.61%
Q1 2024-63.22%
Q4 2023-17.23%
Q3 2023-52.96%
Q2 2023152.88%
Q1 2023-23.01%
Q4 2022-13.86%
Q3 202211.18%
Q2 202243.64%
Q1 2022600.54%
Q4 2021-76.12%
Q3 2021-0.52%
Q2 202169.78%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 20190.00%
Q3 20190.00%
Q2 20190.00%
Q1 20190.00%
Q2 20180.00%
Q1 20180.00%